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The present study uniquely combines olfactory ensheathing glia (OEG) implantation with ex vivo adenoviral (AdV) vector-based neuro-
trophin gene therapy in an attempt to enhance regeneration after cervical spinal cord injury. Primary OEG were transduced with AdV
vectors encoding rat brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), or bacterial marker protein -galactosidase
(LacZ) and subsequently implanted into adult Fischer rats directly after unilateral transection of the dorsolateral funiculus. Implanted
animals received a total of 2 10 5 OEG that were subjected to transduction with neurotrophin-encoding AdV vector, AdV-LacZ, or no
vector, respectively. At 4 months after injury, lesion volumes were smaller in all OEG implanted rats and significantly reduced in size after
implantation of neurotrophin-encoding AdV vector-transduced OEG. All OEG grafts were filled with neurofilament-positive axons, and
AdV vector-mediated expression of BDNF by implanted cells significantly enhanced regenerative sprouting of the rubrospinal tract.
Behavioral analysis revealed that OEG-implanted rats displayed better locomotion during horizontal rope walking than unimplanted
lesioned controls. Recovery of hind limb function was also improved after implantation of OEG that were transduced with a BDNF- or
NT-3-encoding AdV vector. Hind limb performance during horizontal rope locomotion did directly correlate with lesion size, suggesting
that neuroprotective effects of OEG implants contributed to the level of functional recovery. Thus, our results demonstrate that genetic
engineering of OEG not only resulted in a cell that was more effective in promoting axonal outgrowth but could also lead to enhanced
recovery after injury, possibly by sparing of spinal tissue.
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Introduction
Impairment in voluntary motor function after spinal trauma has
often been attributed to disruption of descending motor path-
ways at the injury site (Nathan, 1994). After such damage, very
little regenerative response occurs, resulting in a permanent loss
of function and paralysis. This paucity of regeneration in the
adult mammalian CNS is thought to depend on a negative bal-
ance between factors that inhibit or promote axon growth (for
review, see Schwab and Bartholdi, 1996; Fournier and Strittmat-
ter, 2001). Neurotrophic factor delivery has been studied exten-
sively to overcome inhibition and augment regeneration of spinal
motor pathways, such as the corticospinal tract (CST) and rubro-
spinal tract (RST) (for review, see Jones et al., 2001; Murray and
Fischer, 2001).
Neurotrophins are well known for their beneficial effects on
neuroprotection and neurite outgrowth. Local delivery of neuro-
trophins can counteract pathological events and induce a regen-
erative response after both acute (Schnell et al., 1994; Tetzlaff et
al., 1994) and chronic (Houle and Ye, 1999; Kwon et al., 2002)
spinal cord injury. In addition to intraparenchymal infusions,
genetically modified cells that deliver neurotrophins have been
studied. Engineered fibroblasts (Grill et al., 1997; Liu et al., 1999),
Schwann cells (Menei et al., 1998), and pieces of peripheral nerve
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(Blits et al., 2000) have been used to induce regeneration after
injury. Recently, much research has focused on the use of olfac-
tory ensheathing glia (OEG) that may have advantages over other
cellular conduits (for review, see Franklin and Barnett, 2000;
Plant et al., 2000).
In the adult olfactory neuroepithelium, dying receptor neu-
rons are replaced from a compartment of stem cells in the basal
region of the epithelium (Farbman, 1992). The ability of new
primary olfactory neurons to elongate their axons into a CNS
environment is thought to be related to the presence of OEG
(Doucette, 1990, 1991). These cells uniquely present both
Schwann cell-like and astrocyte-like characteristics (for review,
see Ramon-Cueto and Avila, 1998) and seem to have great po-
tential to repair the damaged spinal cord (Li et al., 1997, 1998;
Ramon-Cueto et al., 1998; Barnett et al., 2000; Ramon-Cueto et
al., 2000; Lu et al., 2001a). However, not all axonal populations
grow into OEG implants (Gudino-Cabrera et al., 2000). Addi-
tional adenoviral (AdV) vector-mediated neurotrophin expres-
sion could enhance their regeneration-supporting properties, be-
cause endogenous neurotrophic factor expression by OEG is low
(Boruch et al., 2001; Woodhall et al., 2001). AdV vector-mediated
gene transfer to OEG results in transient transgene expression for
30 d after implantation in the lesioned rat spinal cord (Ruiten-
berg et al., 2002).
The present experiment represents a new approach to spinal
cord repair by applying ex vivo AdV vector-transduced OEG im-
plants in an attempt to create more conducive conditions for RST
regeneration. We examined the effects of AdV vector-mediated
hypersecretion of brain-derived neurotrophic factor (BDNF)
and neurotrophin-3 (NT-3), two putative RST neurotrophic fac-
tors (Kobayashi et al., 1997; Liebl et al., 2001), on functional
recovery and RST regeneration after cervical injury. Anatomical,
electrophysiological, and functional analysis was used to assess
regeneration in animals over a 4 month observation period.
Materials and Methods
Recombinant AdV stock production. The production of first generation
E1-deleted adenoviral vector stocks encoding the bacterial marker en-
zyme -galactosidase (-gal; AdV-LacZ) (Hermens et al., 1997) or rat
NT-3 (AdV-NT-3) (Dijkhuizen et al., 1997) has been described previ-
ously in detail. For the construction of an AdV vector-encoding BDNF,
total RNA was isolated from adult rat brain. First strand cDNA was
synthesized using reverse transcriptase (Invitrogen, Grand Island, NY)
and oligo-dT primers. Subsequently, BDNF cDNA was amplified from
the total cDNA via a PCR using an upstream sense primer 5-CCC GGA
ATT CGC CAC CAT GAC CAT CCT TTT CCT TAC T-3 and down-
stream antisense primer 5-TTT AGA ATT CCT ATC TTC CCC TTT
TAA TTG GT-3 (Amersham Biosciences, Piscataway, NJ). Primer sets
were designed such that an EcoR1 site and a Kozak sequence (GCCACC;
Kozak, 1987) were introduced in front of the translation startcodon
ATG. The PCR product was then subcloned in the expression plasmid
pcDNA-I/Amp (Invitrogen) downstream of the human cytomegalovirus
(CMV) promoter. Nucleic acid sequencing was performed to identify the
PCR product as rat BDNF cDNA using the United States Biochemicals
sequencing kit (United States Biochemicals, Cleveland, OH). Next,
BDNF cDNA was cloned in the AdV-targeting plasmid pAd309 dlE1.sl/
SalI, yielding the plasmid pAd-BDNF. All targeting plasmids, encoding
LacZ, BDNF, or NT-3, respectively, contained a transgene expression
cassette with the CMV promoter to drive transgene expression and an
SV-40 splice donor–acceptor site and polyadenylation sequence down-
stream of the gene of interest.
Replication-deficient E1-deleted AdV vectors were produced using
standard procedures (Akli et al., 1993). In brief, AdV-targeting plasmid
was linearized by SalI digestion. Linearized targeting plasmid was then
cotransfected with ClaI- and XbaI-digested Ad5 DNA into 911 producer
cells (Fallaux et al., 1996). The following day, cells were overlain with
0.66% agar-containing medium (Invitrogen). After 8 d, lytic plaques
were isolated and characterized by PCR. Plaque-purified recombinant
AdV vector was then expanded on 911 cells, harvested, and purified by
two rounds of CsCl density gradient centrifugation. Recombinant AdV
vector particles were collected from the gradient, dialyzed against TS
buffer (25 mM Tris-HCl, 0.7 mM Na2HPO4, 137 mM NaCl, 6 mM KCl, 1.1
mM MgCl2, 0.9 mM CaCl2), pH 7.4, and stored in small aliquots at80°C
in TS buffer containing 10% glycerol. Viral stock titers were determined
by a plaque assay on 911 cells and expressed as plaque-forming units per
milliliter (pfu/ml). All stock titers used were in the range of 10 10 pfu/ml.
Before use, recombinant AdV vector stocks were screened for the absence
of replication-competent adenovirus as described previously (Hermens
et al., 1997).
Culturing of OEG. The isolation of OEG from the olfactory bulb nerve
layer has been described previously (Yan et al., 2001). Briefly, adult fe-
male Fischer F344 rats were killed by intraperitoneal injection of a lethal
dose of Nembutal ( Rhoˆne-Me´rieux, Pinkenba, QLD, Australia) and
decapitated. The olfactory bulbs were dissected and rapidly transferred to
Leibovitz’s-15 (L-15) medium (Sigma, St Louis, MO). The pia was then
carefully removed under a microscope using fine Dumont forceps. Next,
the ventral olfactory nerve and glomerular layers were dissected away
from the rest of the bulb and cut into 1 mm 3 pieces. Subsequently, tissue
blocks were incubated with 0.25% trypsin (Invitrogen) containing 50
mg/ml DNase (Invitrogen) at 37°C for 60 min with continual shaking.
Trypsinization was stopped by adding DMEM (Sigma) and Ham’s F-12
(DMEM/F-12; 1:1 mixture; Sigma) supplemented with 10% fetal bovine
serum (FBS; df-10S; Invitrogen) and 50 mg/ml gentamicin (Invitrogen).
The suspension was then gently triturated and plated onto poly-L-lysine-
coated 10 cm dishes. Six to seven days after the initial plating, OEG were
purified from contaminated cells by immunoaffinity using the p75 neu-
rotrophin receptor (p75 NTR). For this, 10 cm Petri dishes (Scot Scientific,
Perth, WA, Australia) were incubated overnight at 4°C with goat anti-
mouse antibodies (1:100; ICN Biomedicals, Seven Hills, NSW, Austra-
lia). After several washes, the dishes were incubated with p75 NTR mono-
clonal antibody (generously provided by Dr. P. Wood, University of
Miami School of Medicine, Miami, FL) in L-15 medium supplemented
with 5% FBS for 2 hr at 4°C. Unbound antibody was removed by several
washings with L-15 medium. The cells in primary culture were then
detached by trypsinization, pelleted by centrifugation, and resuspended
in L-15 medium. Next, a 10 ml suspension of olfactory bulb cells was
plated onto pretreated dishes at a density of 4 10 5 cells per dish for 30
min at 4°C. Unbound cells were removed from the dishes during several
washes with L-15 medium. The attached cells were carefully dislodged
from the dishes using a cell scraper (Sarstedt, Newton, NC), centrifuged,
and resuspended in df-10S. Purified cells were then seeded onto poly-L-
lysine-coated 10 cm dishes and fed with df-10S containing mitogens (20
g/ml pituitary extract and 2 M forskolin; Sigma).
Transduction of OEG cultures with AdV vectors. The methods for opti-
mal transduction of primary OEG using AdV vector-mediated gene
transfer have been described recently (Ruitenberg et al., 2002). Briefly,
cells were seeded onto poly-L-lysine-coated six-well plates at a density of
10 5 cells per well. OEG were then fed overnight with df-10S supple-
mented with mitogens (see above). The following day, the medium was
replaced with df-10S containing a lowered mitogen concentration (2
g/ml pituitary extract and 0.2 M forskolin) to minimize OEG prolif-
eration. Because AdV vectors do not integrate into the host cell genome,
proliferation of transduced OEG will lead to the loss of episomally lo-
cated viral DNA and, consequently, transgene expression. Recombinant
AdV vector encoding -gal, BDNF, or NT-3 was added to each well with
a multiplicity of infection (moi) of 100, resulting in the transduction of
virtually all cultured cells (Ruitenberg et al., 2002). Three days after in-
fection, OEG cultures were fixed with 4% paraformaldehyde (PFA) and
0.2% glutaraldehyde in PBS for 10 min at room temperature (RT).
Transduced OEG cultures were then subjected to nonradioactive in situ
hybridization analysis, as described by Giger et al. (1996), using digoxi-
genin (DIG)-labeled antisense cRNA probes specific for -gal, BDNF,
or NT-3.
Neurotrophin production from transduced OEG. Conditioned medium
was collected from transduced OEG cultures to determine the levels of
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secreted AdV vector-derived BDNF and NT-3 via an ELISA, as described
by Woodhall et al. (2001). Transduced cultures of OEG were prepared as
described above. Three days after infection, the medium was refreshed
and the cultures were left for 24 hr, allowing determination of net pro-
duction levels per day. Samples of conditioned medium taken from con-
trol and transduced OEG cultures were rapidly frozen in dry ice– ethanol
and stored at80°C until additional processing.
The Emax immunoassay system (Promega, Leiden, The Netherlands)
was used to determine the levels of neurotrophic factor protein in OEG-
conditioned medium according to the instructions of the manufacturer.
The amount of secreted neurotrophic factor was expressed as nanograms
of BDNF or NT-3 derived from a transduced OEG culture (10 5 cells)
per day.
Biological activity of AdV vector-derived neurotrophins. To determine
whether recombinant BDNF and NT-3 protein was biologically active,
we studied their effect on neurite outgrowth from embryonic dorsal root
ganglion (DRG) explants as described by Dijkhuizen et al. (1997). Puri-
fied OEG (10 4 cells) were seeded onto poly-L-lysine-coated 12 mm glass
coverslips and infected with AdV-LacZ, AdV-BDNF, AdV-NT-3, or no
virus, respectively, as described above.
Three days after AdV vector-mediated transduction of OEG cultures,
embryonic DRGs were removed from timed pregnant female rats.
Briefly, embryonic day (E) 14 pregnant females were killed by an intra-
peritoneal overdose of Nembutal and decapitated. Next, the entire litter
was rapidly removed by Cesarean section and transferred to wet ice-
cooled L-15 medium. E14 lumbar DRGs were then aseptically dissected
from rat embryos and pooled in ice-cold L-15 medium. Isolated DRGs
were subsequently transferred to DMEM/F-12 medium (1:1 mixture),
and the medium from OEG cultures was removed by aspiration. Single
DRGs were taken up in 50l of DMEM/F-12 medium and plated on top
of AdV vector-transduced OEG monolayers. Cocultures of OEG and
DRG explants were grown for an additional 24 hr in a CO2 incubator
(5%) at 37°C.
To visualize neurite outgrowth, cocultures were fixed with 4% PFA in
PBS for 30 min. Fixed cultures were subsequently washed several times
with Tris-buffered saline (TBS; 10 mM Tris-HCl, 135 mM NaCl), pH 7.4,
and permeabilized with TBS containing 0.3% Triton X-100 and 5% FBS.
Cultures were then incubated overnight with the mouse monoclonal
antibody 2H3 against rat neurofilament (NF) (1:1000; Developmental
Studies Hybridoma Bank, University of Iowa, Iowa City, IA) at 4°C. The
following day, cultures were washed three times with TBS and incubated
with Cy3-conjugated secondary antibody [1:400; donkey anti-mouse
(DAM)-Cy3; Jackson ImmunoResearch, West Grove, PA]. Finally, co-
cultures were mounted in Vectashield (Vector Laboratories, Burlingame,
CA) and coverslipped. Digital photographic images of neurite outgrowth
from each DRG explant were then captured using a Zeiss (Thornwood,
NY) confocal laser-scanning microscope (CLSM).
Preparation of OEG for spinal implantation. Suspensions of OEG for
implantation purposes were prepared as described previously (Ruiten-
berg et al., 2002). Primary p75 NTR-purified OEG were seeded onto poly-
L-lysine-coated 6 cm dishes at a density of 10 6 cells per plate and grown
overnight in df-10S containing 2 g/ml of pituitary extract and 0.2 M
forskolin. The following day, the medium was replaced with fresh me-
dium containing either no AdV vector or 10 8 pfu (moi, 100) AdV-LacZ,
AdV-BDNF, AdV-NT-3, or AdV-BDNF plus AdV-NT-3, respectively,
and the cells were left for 72 hr. OEG cultures were then prelabeled with
10 g/ml of Hoechst 33342 dye (bis-benzimide; Sigma) and subse-
quently washed several times with L-15 medium. Next, the cells were
detached by trypsinization and washed twice in serum-free DMEM/F-12
medium. Cells were pelleted by low-speed centrifugation, carefully re-
suspended, and diluted in the appropriate volume of DMEM/F-12 me-
dium to obtain a suspension of 10 5 OEG per microliter, as determined by
counting. The viability of OEG suspensions was determined by counting
the percentage of dead cells using Trypan blue staining. In all cases, the
viability of OEG suspensions before implantation was 95%. Suspen-
sions were kept cool on wet ice during surgery.
Experimental design. A total of 68 adult female Fischer F344 rats (175–
200 gm; Harlan-Olac, Oxon, UK) were used in this experiment. All rats
were housed under standard conditions, maintained in a 12 hr light/dark
cycle, and had ad libitum access to water and food. All experimental
procedures were conducted in accordance with the guidelines of the local
animal welfare committee for use and care of laboratory animals. Body
weight of experimental animals was monitored during the experiment as
a general measure of health. Animals were divided into six experimental
groups. Experimental group 1 (n  10), which serves as a control, was
subjected to a unilateral transection of the dorsolateral funiculus of the
cervical spinal cord. Rats in experimental groups 2, 3, 4, 5, and 6 received
a similar spinal cord lesion but also an implant of either control or AdV
vector-transduced OEG. Animals in groups 2 and 3 received an implant
of uninfected OEG (n  10) or AdV-LacZ-transduced OEG (n  12),
respectively. These groups served as additional controls. In groups 4, 5,
and 6, OEG were subjected to infection with AdV vectors encoding
BDNF or NT-3 before implantation. Rats in experimental groups 4 and 5
received an implant of AdV-BDNF (n  12) or AdV-NT-3-transduced
(n 12) OEG, respectively. In group 6, OEG were subjected to infection
with a 1:1 mixture of BDNF- and NT-3-encoding AdV vector and sub-
sequently implanted in the lesioned spinal cord (n  12). All rats were
tested weekly for 4 months for recovery of hind limb performance.
Rubrospinal projections in these animals were then anterogradely la-
beled using biotinylated dextran amine (BDA) as a tracer 2 weeks before
the animals were killed. Rubrospinal motor-evoked potentials (MEPs)
were recorded for all experimental animals before perfusion to study
regeneration of RST axons and integrity of descending spinal pathways in
general. Seven days after implantation, two animals were taken from
groups 3– 6 and evaluated for transgene expression.
Surgical procedures. Implantation of OEG into a unilateral cervical
transection injury model involving the RST was described previously in
detail (Ruitenberg et al., 2002). In brief, rats were deeply anesthetized by
intramuscular injection of ketamine (100 mg/kg of body weight; Ni-
matek, Eurovet, Bladel, The Netherlands) and xylazine (10 mg/kg of
body weight; Bayer, Leverkussen, Germany). Access to the spinal cord
was obtained via dorsal laminectomy of the fourth cervical vertebra after
splitting the neck musculature. To expose the spinal cord, a small inci-
sion was made through both dura and pia mater using a sharpened 30 ga
needle. After identification of the dorsal root entry zone and midline of
the spinal cord, the left dorsolateral funiculus of the spinal cord was
lesioned with a pair of microscissors as deep as 1 mm ventral to the spinal
surface, taking care not to damage the dorsal roots. Such a lesion resulted
in complete transection of the RST projection area and slightly damaged
the spinal gray matter. Next, OEG suspensions were carefully injected at
1 mm distance, both proximal and distal, from the lesion cavity using a
Harvard microinjection apparatus. Each injection delivered 10 5 cells.
After removal of the injector, muscles and skin were closed in separate
layers. All animals received a postoperative subcutaneous injection of 2
ml physiological salt solution to compensate for blood loss and Finadyne
(flunixinum, 2.4 mg/kg of body weight for 3 d; Schering-Plough, Brus-
sels, Belgium) to suppress pain. At the end of surgical procedures, the
viability of OEG suspensions used for implantation still ranged between
90 and 95%, as determined by Trypan blue staining.
Locomotor analysis. After surgery, spinal cord-injured rats were al-
lowed to recover for a period of 7 d before the assessment of locomotor
capacity. Functional performance of the impaired hind limb was inves-
tigated via the Basso–Beattie–Bresnahan (BBB) locomotor rating scale
(Basso et al., 1995) and during horizontal rope walking (Kim et al., 2001).
In both cases, gait analysis of spinal cord-injured rats was postoperatively
determined by two independent investigators that were blinded to the
treatment of the animal. The first functional assay, the BBB rating score,
was composed of 21 operational definitions studying several aspects in-
volved in the locomotion of quadrupedal animals. As a more sensitive
test to assess behavioral deficits in partial spinal cord hemisection mod-
els, horizontal rope walking was used to study more specific aspects such
as posture and balance during gait. In this test, animals were trained to
walk across a 1.25-meter-long rope (diameter, 4 cm) from one platform
to another while the gait of the animal was studied. To successfully com-
plete this task, hind limb weight support, precise paw placement, and
adaptable balance were required. Animals were pretrained for a period of
5 weeks before the start of the experiment, such that a constant rope
locomotion performance was obtained. Trained animals crossed the
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rope quickly with an occasional minor slip and no falls. Rats were scored
for their general performance during rope locomotion using a deficit
rating scale defined as follows: (0) normal rope locomotion with rare
minor deficits; (1) close to normal locomotion with occasional lesion
deficits; (2) able to cross the rope but with obvious lesion deficits such as
inability to maintain consistent weight-supported limb placement dur-
ing traverse; or (3) great difficulty to cross the rope, frequent slips, and
falls. To determine ratings, rats were given two conditioning trials and
subsequently evaluated for forelimb and hindlimb placement together
with general balance and posture during traverse. As they moved along
the rope, all rats were also videotaped from a stationary lateral view,
allowing us to determine the “total error/step” ratio. This quantitative
analysis method included counting the number of slips and falls during
rope traverse. From these data, a total error/step ratio was calculated and
defined as the following: [number of slips  2(number of falls)]/total
number of steps. Each rat was observed three times, and final scores were
either the mean of three independent observations (quantitative analy-
sis) or the cumulative deficit score of three runs (maximum deficit score
of 9), according to Kim et al. (2001).
RST axon tracing. Anterograde labeling of the RST was performed as
described previously (Antal et al., 1992), using biotin– dextran conju-
gates (10% BDA, 10,000 molecular weight in PBS) (Molecular Probes,
Leiden, The Netherlands) as a neuronal tracer, 14 d before perfusion. In
brief, a small hole was drilled in the skull under deep ketamine–xylazine
anesthesia while the animal was held in a stereotaxic frame. Glass pipettes
with a tip diameter of 60 m were filled with BDA tracer that was subse-
quently delivered to the red nucleus using iontophoresis. The stereotaxic
coordinates for tracer delivery were, with horizontal skull position, 6 mm
posterior and 0.7 mm lateral to bregma and 6.8 mm deep from the dorsal
surface of the brain. A positive direct current of 6 A (Vmax, 30 V) was
used with a pulse duration of 5 sec followed by 5 sec intervals for a period
of 20 min. The current was then switched off and the injector was left in
place for 5 min to allow diffusion of BDA from the injection spot. Polarity
of the current was then changed, followed by the careful withdrawal of
the glass capillary and suturing of the skin.
Electrophysiology. At the end of the experiment, after conclusion of the
behavioral analysis at 4 months after injury, rubrospinal MEPs were
recorded as described previously (Lankhorst et al., 1999) to evaluate
possible RST axon regeneration. Briefly, animals were deeply anesthe-
tized with hypnorm (0.4 ml/kg of body weight, i.m.; Janssen Pharmaceu-
tical LTD, Grove, Oxford, UK) containing 0.315 mg/ml of fentanyl ci-
trate and 10 mg/ml of fluanisone. Hypnorm injections were repeated
every 30 min after induction of the anesthesia. Subsequently, the animals
were intubated and mechanically ventilated after a neuromuscular
blockade with pancronium bromide (1.25 mg/kg of body weight, i.v.;
Organon, Oss, The Netherlands). Rubrospinal MEPs were elicited by
direct bipolar stimulation (SNEX-100x; 20 mm; Bilaney Consultants,
Dusseldorf, Germany) of the lesioned right red nucleus (stereotaxic co-
ordinates as for tracer delivery) and recorded below vertebra C5 via an
epidurally located bipolar recording electrode consisting of thin gold
plates and with an interpolar distance of 5 mm. Threshold values were
subsequently determined by slowly increasing the applied voltage. All
MEPs used for analysis were measured at twice the threshold value. To
ensure that evoked potentials were derived from the lesioned red nucleus
and not, in part, the result of cross-stimulation of the intact RST, the right
lateral funiculus was transected at the level of vertebrae C3. Such a lesion
completely destroyed the RST that originated from the left red nucleus,
yielding the MEP signal that was attributable to stimulation of the right
red nucleus. Immediately after recording of rubrospinal MEPs, animals
were killed by transcardial perfusion with 100 ml of saline followed by
300 ml of ice-cold 4% PFA in PBS. Brains and spinal cords were carefully
dissected, postfixed overnight in 4% PFA solution, and stored in 0.1%
PFA in PBS containing 0.01% NaN3 at 4°C until additional use.
For MEP analysis, a total of 1024 traces were averaged to improve the
signal/noise ratio. Within the mean trace, deviations from the signal
baseline were considered as a peak if the top-valley voltage difference was
at least three times as large as the SD of the noise. The amplitude and
latency of the first (monosynaptic) positive peak, as well as the summed
amplitudes of all peaks during the first 5 msec (stimulus artifact was
discarded), were determined and included in the analysis.
Histological analysis. To evaluate transgene expression 7 d after im-
plantation, horizontal sections through the cervical spinal cord were cut
on a cryostat and subjected to standard in situ hybridization using DIG-
labeled cRNA antisense probes against BDNF or NT-3 mRNA. Consec-
utive sections were double labeled with p75 NTR to identify the nature of
transgene-expressing cells and astrocyte marker glial fibrillary acidic pro-
tein (GFAP; 1:5000; Dako, Glostrup, Denmark). After perfusion of the
experimental animals, at 4 months after injury, fixed spinal cords (cervi-
cal region, C2–C6) were washed several times with PBS, embedded in
10% gelatin (Difco, Detroit, MI), and postfixed for 48 hr in 4% PFA
solution at 4°C (Griffioen et al., 1992). Four series of consecutive hori-
zontal vibratome sections (40m) were cut in PBS and collected in serial
vials.
BDA-traced RST axons were visualized for quantification purposes by
staining two alternate series of the horizontal spinal cord sections (50%
of all sections). In brief, sections were washed three times in TBS, fol-
lowed by irreversible blocking of endogenous peroxidase activity with
10% methanol and 3% H2O2 in TBS for 1 hr at RT. Subsequently, sec-
tions were washed three times and incubated for 30 min with TBS sup-
plemented with 5% FBS and 0.3% Triton X-100. Sections were then
incubated overnight with avidin– biotin–peroxidase complex at 4°C (1:
800 avidin plus 1:800 biotin; PK-6100 Elite Vectastain ABC-kit; Vector
Laboratories, Burlingame, CA). The following day, sections were washed
three times in TBS and incubated with biotinylated tyramid (1:1000;
Dako) for 10 min in TBS containing 0.01% H2O2 to allow signal ampli-
fication. Sections were washed again three times and incubated with ABC
reagent for 1 hr at RT. After several washes, sections were stained with
3,3-diaminobenzidine tetrahydrochloride (DAB) in 50 mM Tris-HCl,
pH 7.4, containing 0.01% H2O2 and 0.2 mg/ml of (NH4)2SO4NiSO4
resulting in a dark purple precipitate. Sections were subsequently dehy-
drated in graded series of ethanol, cleared in xylene, and finally embed-
ded in Entellan (Merck, Amsterdam, The Netherlands). To better visu-
alize the spatial relationship of BDA-traced RST axons with the lesion
and implantation site, camera lucida drawings of representative sections
through the injured dorsolateral funiculus were made.
The third set of sections was used to examine in more detail the spatial
relationship of BDA-traced RST axons and the glial scar using DAB dou-
ble staining as described previously (Buijs et al., 1999). To this end,
free-floating sections were pretreated as described above and incubated
overnight with ABC reagent to stain traced RST axons. Next, the DAB
color reaction was stopped via three washes with TBS followed by a 10
min incubation with 10% methanol and 3% H2O2 containing TBS to
block peroxidase activity. Sections were then incubated overnight with a
rabbit polyclonal antibody against GFAP (1:5000; Dako) at 4°C. The
following day, unbound antibodies were washed away with multiple
washings in TBS, and sections incubated with a horseradish peroxidase-
conjugated secondary antibody were directed against rabbit immuno-
globulins (1:200; Dako). Sections were stained as described above using
DAB as a chromogen but without the addition of (NH4)2SO4NISO4.
This results in the formation of a brown immunoprecipitate that can be
clearly distinguished from dark purple-stained RST axons. Sections were
mounted on gelatin-coated slides and dried overnight at RT. The sections
were then briefly counterstained with 0.2% cresyl violet solution, dehy-
drated in ethanol, and finally embedded in Entellan as described above.
The fourth and final set of vibratome sections was used to either gain
an impression of the severity of scar formation at the lesion site at 4
months after injury, or to visualize regenerating axons in the lesion area.
For this, p75 NTR immunoreactivity was used as a general marker to
visualize implanted OEG at the lesion site and combined with staining for
NF or fibronectin. The latter antibody will stain p75 NTR-negative men-
ingeal cells and fibroblasts that may have invaded the lesion site (Pas-
terkamp et al., 1999). In brief, sections were washed three times with TBS
and permeabilized with TBS containing 0.3% Triton X-100 and 5% FBS
to block nonspecific binding of antibodies. Sections were then incubated
overnight with primary antibodies against p75 NTR (1:50; mouse mono-
clonal antibody clone 192; Chemicon, Harrow, UK) and fibronectin (1:
50; rabbit polyclonal antibody; Chemicon) or NF (1:100; NF-200; Sigma)
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at 4°C. The following day, sections were washed with TBS and incubated
with a mixture of fluorophore-conjugated secondary antibodies for 1 hr
at RT: swine anti-rabbit-FITC and DAM-Cy3 (1:400; Jackson Immu-
noResearch). Sections were mounted on slides and immersed in Vectash-
ield. Digital photographic images were captured using a Zeiss CLSM
device.
Quantification of RST axon numbers and lesion size. To quantify regen-
eration or sprouting of traced RST axons, BDA-positive axonal profiles
in the lesion area were counted as described by Blits et al. (2000). First, the
proximal border of the scar was determined using a dark-field filter and
considered as “point 0.” Lesion borders were defined as a clear disconti-
nuity of normal spinal cord cytoarchitecture, the absence of healthy-
looking spinal neurons, and a high density of small cells [i.e., implanted
OEG and endogenous cells (e.g., inflammatory cells) that are known to
invade spinal cord injury sites] as described previously (Takami et al.,
2002; Plant et al., 2003). Fiber counts were made at fixed distances up to
several millimeters proximal and distal to this point. For this, a 65 m
width frame was projected on the horizontal sections at 3, 2, 1.5, 1, 0.75,
0.5, 0.25, and 0 mm proximal or distal to the proximal border of the
lesion (point 0). All BDA-positive axons visible within this frame were
then counted at 200magnification by an independent investigator who
was blinded to the treatment of the animals. To correct for variability in
the tracing results, relative RST axon numbers were calculated by ex-
pressing the fiber counts at each distance as a percentage of traced RST
axons at 3 mm proximal to point 0.
To assess possible counteracting effects of different OEG implants on
the ongoing secondary degeneration at the injury site, lesion volumes of
all experimental animals were determined using a computerized image
analysis station. In brief, the same sections used for RST axon quantifi-
cation (described above; 50% of total sections) were studied under dark-
field microscopy, and the border of the damaged area was determined
using the same criteria as described above. Next, lesion areas were out-
lined while the observer was blinded to the experimental treatment. The
outlined area contained both scar-associated cells as well as grafted OEG,
and in a rare occasion, some small cysts if present (primarily in unim-
planted lesioned control animals). The outlined areas of each animal
were subsequently imported into Microsoft (Seattle, WA) Excel,
summed, multiplied by the section thickness, and corrected for the total
number of sections.
Statistical analysis. Data obtained from histological analysis and elec-
trophysiology, as well as the calculated total error/step ratios, were ana-
lyzed for statistical differences between animal groups ( p 0.05) using
two-way ANOVA and post hoc Newman–Keuls tests. Functional data
from the rope locomotion-rating scale (deficit scores) were evaluated
using nonparametric Kruskall–Wallis ANOVA test. The Pearson corre-
lation test was used to investigate whether there were possible relation-
ships between different outcome parameters and were considered statis-
tically significant if p  0.01. All data incorporated in the analysis were
obtained from animals that survived the entire study.
Results
In vitro analysis of transgenic neurotrophin expression
Transduction of primary p75 NTR-purified OEG cultures with
first-generation E1-deleted adenoviral vectors resulted in high
levels of transgene expression in many cells as determined by in
situ hybridization at 3 d after infection (data not shown). Numer-
ous cells expressed high levels of -gal, BDNF, or NT-3 mRNA,
respectively, without signs of toxicity or cytopathological effects.
No staining for any of the transgenes was observed in uninfected
OEG that served as control cultures or after hybridization with
sense probe.
Conditioned medium from transduced OEG cultures was an-
alyzed for the presence of neurotrophins BDNF and NT-3 using
an ELISA assay 4 d after transduction with AdV vectors (Fig. 1A).
Low levels of BDNF were detected in medium samples (n  4)
taken from control (0.45 	 0.17 ng/10 5 cells per day) or AdV-
LacZ-transduced OEG cultures (0.57 	 0.13 ng/10 5 cells per
day), whereas NT-3 was not detectable. After infection with AdV-
BDNF, an100-fold increase in the levels of BDNF (43.8	 6.8
ng) secreted from transduced OEG was observed. ELISA analysis
of medium samples taken from AdV-NT-3-transduced OEG cul-
tures revealed that at least 50.8	 3.7 ng of recombinant NT-3 was
secreted from 10 5 cells per day. These results indicate that, at the
time-point of implantation, high amounts of recombinant neu-
rotrophin were released from OEG transduced with an AdV
vector-encoding BDNF or NT-3 as compared with controls.
Figure 1. In vitro analysis of AdV vector-mediated transgene expression. A, Conditioned
medium from uninfected and AdV-LacZ (controls) or neurotrophin-encoding AdV vector-
transduced OEG cultures (10 5 cells) was analyzed for the presence of BDNF and NT-3 using ELISA
techniques. Bars indicate averages	 SEM (n4). At 4 d after transduction, low levels of BDNF
(0.5 ng) were found secreted in medium taken from control OEG cultures over a 24 hr time
period, whereas NT-3 was not detectable (N.D.). Transduction of OEG cultures with
neurotrophin-encoding AdV vectors resulted in high levels of recombinant BDNF and NT-3,
secreted into the culture medium at a net rate of 43.8	 6.8 ng and 50.8	 3.7 ng/10 5 cells per
day, respectively. B–E, Biological activity of AdV vector-derived BDNF and NT-3 was confirmed
in a 24 hr coculture experiment of transduced OEG and E14 DRG explants. This allowed visual-
ization of the additional effect of transgenic neurotrophin expression on the neurite outgrowth-
promoting properties of OEG. Similar moderate outgrowth of neurites was observed when DRG
explants were grown on top of uninfected ( B) or AdV-LacZ-transduced ( C) OEG cultures. This
indicates that AdV vector infection itself did not alter the growth-promoting properties of these
cells. Robust neurite outgrowth was observed from DRG explants cocultured with OEG trans-
duced with an AdV vector-encoding BDNF ( D) or NT-3 ( E). This demonstrates that AdV vector-derived
neurotrophins were secreted from OEG in biologically active form, and that these transduced OEG
were more effective in promoting neurite outgrowth in culture. Scale bar: (in E) B–E, 1 mm.
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Biological activity of AdV vector-
derived BDNF and NT-3 was demon-
strated in a coculture experiment. For this,
E14 DRG explants (n  12) were posi-
tioned on top of an AdV vector-
transduced monolayer of OEG to deter-
mine the effect of transgenic neurotrophic
factor production and were subsequently
analyzed for neurite outgrowth 24 hr after
the initial plating. Moderate extensions of
neurites were observed when E14 DRG ex-
plants were cocultured with uninfected or
AdV-LacZ-transduced OEG (Fig. 1B,C).
No visible differences in radial neurite
outgrowth were observed between these
groups, indicating that AdV vector infec-
tion did not interfere with the growth-
supporting properties of OEG. A robust
outgrowth of neurites from DRG explants
was found when OEG monolayers were
transduced with an AdV vector-encoding
BDNF or NT-3 (Fig. 1D,E). These results
demonstrate that AdV vector-derived
neurotrophins were biologically active and
confirm that recombinant BDNF and
NT-3 were secreted by transduced OEG as
shown previously by ELISA.
In vivo analysis of transgene expression
At 7 d after implantation, transgene ex-
pression in OEG implants was examined
by in situ hybridization and immunohisto-
chemical characterization of the lesion
area (Fig. 2). Numerous cells displaying
typical bipolar OEG morphology were de-
tected in the lesion area expressing high
levels of BDNF or NT-3 mRNA. No such
staining was present in unimplanted ani-
mals or after implantation of AdV-LacZ-
transduced OEG (data not shown). To de-
termine the identity of BDNF- and NT-3-
expressing cells, adjacent sections were
examined for the presence of Hoechst-
labeled cells and immunoreactivity for
p75 NTR, which is a marker for OEG. No
BDNF- or NT-3-expressing cells were
present outside the confines of p75 NTR im-
munoreactivity and Hoechst distribution
pattern, identifying them as being im-
planted OEG. The vast majority of BDNF-
and NT-3-positive cells were present in the
inner core of the lesion, bridging the injury site as determined by
GFAP staining that was used to visualize the developing glial scar.
Some additional p75 NTR labeling was observed at the lateral edges
of the spinal cord close to or in the dorsal root itself, indicating
the presence of Schwann cells.
Histological analysis
Double staining for fibronectin and p75 NTR was used to visualize
scar-associated cells, such as meningeal cells and fibroblasts, and
implanted OEG, respectively. At 4 months after the injury, abun-
dant fibronectin expression was found in unimplanted animals
delineating the scar, but only a minor immunoreactivity for
p75 NTR could be detected (Fig. 3A). The majority of these
p75 NTR-labeled cells was found in the more lateral part of the
lesion, close to the dorsal root entry zone. Most of these cells
displayed typical bipolar morphology (Fig. 3A, inset), indicating
that they were most likely Schwann cells that had migrated into
the spinal cord after the injury. In contrast, high levels of p75 NTR
immunoreactivity were observed in all implanted animal groups,
labeling many cells at the injury site but not rostral or caudal to it
(Fig. 3B). This indicates that implanted OEG were able to survive
in the spinal cord for at least 4 months after implantation, be-
cause only a few p75 NTR-positive Schwann cells were found to
invade the spinal cord. Clusters of aligned p75 NTR-positive cells,
Figure 2. In vivo analysis of AdV vector-mediated neurotrophin expression by transduced OEG after implantation in the
lesioned spinal cord. At 7 d after implantation, many cells expressing high levels of BDNF and NT-3 mRNA were detected in the
lesion area. Animals implanted with uninfected or AdV-LacZ-transduced OEG (control implants) did not display such neurotrophin
mRNA expression at the injury site. Transgene-expressing cells were nicely integrated in the host spinal cord bridging the injury
site. Histological analysis of adjacent sections showed that these cells were detected within the confines of p75 NTR immunoreac-
tivity, which identifies them as implanted OEG. Some additional labeling for p75 NTR (Schwann cells) was found at the lateral edges
of the spinal cord, at the level of the dorsal root (dr) entry zone (dashed line). Visualization of the developing glial scar showed that
the vast majority of transgene-expressing cells was present in the lesion center and surrounded by GFAP-positive reactive astro-
cytes. Scale bar, 100m.
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presumably implanted OEG, together with some endogenous
Schwann cells were surrounded by small fibronectin-positive
cells, most likely derived from the meningeal sheets (Pasterkamp
et al., 1999). When combined with axonal staining, few NF-
positive axon-like structures were found in the lesion area of
unimplanted controls (Fig. 3C), whereas a dense network of NF-
positive axons was detected in OEG-implanted rats, often in close
association with p75 NTR-positive cells (Fig. 3D).
Anterograde tracing revealed that implantation of OEG did
not result in robust long-distance regeneration of RST fibers un-
der any condition. In unimplanted animals, the vast majority of
traced RST axons (black) displayed “end bulb”-like structures at
the proximal border of the lesion site, in the GFAP-positive
(brown) area, and did not penetrate into the central component
of the scar tissue (Fig. 4A,C). In animals that received an implant
of uninfected, AdV-LacZ- or AdV-NT-3-transduced OEG, re-
spectively, no obvious difference in the distribution of RST axons
was observed compared with nonimplanted animals (Fig.
4B,D,E). However, extensive BDNF-mediated sprouting of RST
axons was observed in animals that received an OEG implant that
was transduced with AdV-BDNF alone or together with AdV-
NT-3. Sprouting of RST axons preferentially occurred along the
interface of the injury site and astrocytic scar (Fig. 4F). In many
cases, aberrant and undirectional sprouting of RST axons was ob-
served (Fig. 4G,I). Sprouting of RST axons
was primarily restricted to the lesion area,
with a small number of fibers extending be-
yond the lesion and implantation site in the
distal spinal cord. However, most of these
axons were still in close proximity of the in-
jury site (Fig. 4H,J). From each experimen-
tal group, camera lucida drawings through
the lesion area of a representative animal
were generated to visualize the spatial rela-
tionship of traced RST axons to the lesion
area (Fig. 5). Microscopic observations were
confirmed by quantitative analysis of the re-
generative response of rubrospinal neurons
to different OEG implants (Fig. 6). Fiber
counts of BDA-traced RST axons revealed
that no statistical differences were present
between animal groups that received either
no treatment (n 6) with an implant of un-
infected OEG ( p  0.52; n  9) or AdV-
LacZ-transduced OEG ( p  0.12; n  6),
respectively. AdV vector-mediated hyperse-
cretion of NT-3 from transduced OEG also
failed to induce growth of RST axons or
counteract axonal “dieback” ( p 0.28; n
7). In all cases, a similar distribution pattern
and dieback of RST axons was observed; al-
though, a consistent tendency toward lim-
ited local sprouting seemed present in these
OEG implanted groups. These data indicate
that RST axons were not overly attracted by
OEG implants, and an additional AdV
vector-mediated expression of NT-3 by im-
planted cells did not evoke a regenerative re-
sponse of RST axons. As expected from the
histological observations, a statistically sig-
nificant BDNF-mediated sprouting of RST
axons was found in animal groups 4 ( p 
0.0002; n  5) and 6 ( p  0.004; n  7)
compared with all other animal groups. No statistical differences
were found between these two groups ( p  0.33), indicating that
coexpression of BDNF and NT-3 had no synergistic or counteract-
ing effect on the level of RST axon sprouting.
Volumetric analysis of the injury site revealed that a consistent
trend toward smaller lesion volumes was present in all OEG im-
planted rats compared with controls (Fig. 7). However, no statis-
tically significant differences from unimplanted controls (n 6)
were reached in animals implanted with uninfected OEG ( p 
0.08; n  9) or AdV-LacZ-transduced OEG ( p  0.11; n  6),
respectively. In contrast, lesion volumes were almost reduced by
half in animals that received OEG implants transduced with AdV
vectors encoding BDNF ( p 0.008; n 5), NT-3 ( p 0.01; n
9), or a mixture of both vectors ( p 0.004; n 7). This indicates
that AdV vector-mediated secretion of BDNF and NT-3 counter-
acted secondary degeneration of neural tissue after experimental
spinal cord injury.
MEP analysis
In unoperated age-matched controls, unilateral stimulation of
the red nucleus resulted in the recording of a few detectable peaks
at the level of cervical vertebra C6 (Fig. 8). The first peak repre-
sents the direct projection from the red nucleus, and its ampli-
tude (a direct measure for the number of RST axons) is signifi-
Figure 3. Immunohistochemical characterization of the lesion area at 4 months after injury. A, B, Staining for fibronectin
(green) was used as a marker to visualize scar-associated meningeal cells and fibroblasts in the lesion area and combined with
immunohistochemistry for p75 NTR (red) as a general antigenic marker for implanted OEG. A, In unimplanted controls, fibronectin
was highly expressed in the lesion area with only little immunoreactivity for p75 NTR. Fibronectin-positive cells were found to fill
the lesion gap, and virtually no cystic cavity formation was observed. Most of the p75 NTR-stained cells displayed typical bipolar
Schwann cell morphology (inset is a higher magnification of the outlined area) that may have migrated into the lesion area from
the dorsal root. B, Abundant and elevated p75 NTR immunoreactivity was found in the lesion area of all OEG implanted animals,
indicating that apart from the endogenous Schwann cells present, grafted cells did survive in the lesioned spinal cord. C, D,
Representative confocal microscope images of the lesion center of an unimplanted control and typical OEG-implanted rat, respec-
tively, at higher magnification. Immunohistochemistry for p75 NTR (red) was combined with staining for neurofilament (green) to
visualize all axons present in this area. C, Few axons were detected in the lesion center of unimplanted controls (arrows), some of
them displaying typical end bulb-like structures (arrowhead). D, In all OEG-implanted rats, numerous NF-positive axons were
found in the graft area, often aligning with bipolar p75 NTR-positive cells (arrows). This indicates that several unidentified popu-
lations of spinal axons were able to regenerate through the OEG implantation site. Scale bars: A, B, 100m; C, D, 25m.
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cantly decreased after transection of the
dorsolateral funiculus ( p  0.001). The
other detectable peaks represent different
unidentified descending spinal pathways
that are either costimulated during MEP
recording or part of the larger motor sys-
tem that involves the red nucleus. In line
with our histological observations, no sig-
nificant differences in rubrospinal MEP
recordings were found among different
experimental animal groups ( p  0.05;
data not shown), indicating the absence of
robust long-distance regeneration of ax-
ons beyond OEG implants (Fig. 8).
Analysis of functional recovery
Behavioral analysis of spinal cord-injured
rats during overground locomotion (BBB
score) did not reveal detectable functional
deficits in the open field. Although a tran-
sient impairment was observed during the
initial postoperative phase in both the left
forelimb and hindlimb, animals seem to
fully recover from the injury regardless of
treatment (data not shown). This demon-
strates that the BBB rating score is an inap-
propriate assay for evaluation of hindlimb
function recovery after partial transection
of the dorsolateral funiculus, as stated pre-
viously (Kim et al., 2001). In contrast, a
persistent impairment in especially ipsilat-
eral hindlimb function was detected dur-
ing horizontal rope walking, emanating in
slips of the hindlimb or even a fall from the
rope (Fig. 9A). Such impairment was not
present during pretraining of the animals
before spinal injury. In all operated ani-
mals, remaining deficits in general loco-
motion and hindlimb performance were
observed. However, a statistically signifi-
cant main treatment effect in deficit scores
was found ( p  0.0002) (Fig. 9B). This
indicates that all OEG implanted rats had a
consistently improved locomotion and
slipped or fell from the rope less frequently
than unimplanted control animals. As ex-
pected, no differences in locomotor be-
havior were found between animals that
received an implant of uninfected or AdV-
LacZ-transduced OEG, respectively ( p 
0.99). This demonstrates that ex vivo
transduction of OEG itself, using AdV
vector-mediated gene transfer, did not in-
terfere with the behavioral outcome. In
addition, rope locomotion behavior was
consistently better in animals that received
an OEG implant that was transduced with
a neurotrophin-encoding AdV vector
( p  0.00002). Apart from the fact that
these rats made fewer errors during rope
traverse, other locomotion aspects, in par-
ticular body posture and hindpaw place-
ment, were superior in these groups com-
Figure 4. The regenerative response of lesioned RST axons to different types of AdV vector-transduced OEG implants 4 months
after injury. All experimental animals were traced with BDA, which was iontophoretically applied 2 weeks before perfusion.
Representative photomicrographs of horizontal sections through the cervical spinal cord show anterograde BDA-traced RST axons
(black) and reactive GFAP-positive astrocytes (brown) at the lesion and OEG implantation site. DAB double staining was combined
with cresyl violet counterstaining (blue) to better visualize tissue cytoarchitecture. In all cases, left is rostral (proximal to the
injury), and dashed lines indicate graft– host interfaces. A, C, Traced RST axons proximal to the lesion in an unimplanted control
animal. C, Higher magnification of the outlined area in A, showing that RST axons (arrows) did not regenerate into the lesion area
(asterisk), and all stopped at the proximal border of the scar delineated by GFAP-positive astrocytes. B, Termination of lesioned
BDA-traced RST axons at the lesion site after implantation of AdV-LacZ-transduced OEG. No sprouting of the RST into the graft and
lesion area was observed. D, E, Higher magnifications of the corresponding areas outlined in B, showing end bulb-like axon
endings at the proximal graft– host boundary (arrows). Similar distribution patterns of traced RST axons were found when OEG
had been transduced with no or AdV-NT-3 vector before implantation. F–J, RST axon sprouting in representative animals after
implantation of AdV-BDNF-transduced OEG. F, RST axon regeneration into the graft was observed. The dashed line indicates the
rostral graft– host interface as determined using dark-field microscopy (inset; asterisk, blood vessel; wm, white matter). Sprout-
ing preferentially seemed to occur along the graft– host interface (arrows) with some axons present in the central core of the
lesion and implantation site (arrowhead). G, Traced RST axons deeper in the graft (arrows). H, BDA-labeled RST axons at the caudal
graft– host interface. I, Higher magnification of the outlined area in G, showing undirectional growth of RST axons (arrow). J,
Higher magnification of corresponding area in H. Few axons were found to leave the graft and extend distally into the host spinal
cord (arrow). Scale bars: A, 220m; B, C, F–H, 92m; D, E, 36m; I, J, 23m.
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pared with animals from control groups (lesion only or control
OEG implant) (Fig. 9A). These observations were reflected in the
significantly lower deficit scores. Interestingly, within all experi-
mental groups, no significant additional improvements in func-
tional performance were found after the first month after surgery.
This indicates that recovery of function primarily occurred dur-
ing the first 4 weeks after injury and OEG implantation.
Calculated total error/step ratios were consistent with the be-
havioral data as obtained from the deficit-scoring method (Fig.
9C). Significant treatment-based differences were found among
the experimental groups. All OEG-implanted animal groups dis-
played an improved recovery after the injury resulting in signifi-
cantly lower error scores (fewer slips or falls) than unimplanted
lesioned control rats ( p 0.0003). Again, no statistical difference
( p 0.57) in horizontal rope locomotion performance was found
among rats that received an implant of either uninfected or AdV-
LacZ-transduced OEG. Enhanced recovery was observed in animal
groups that received OEG implants subjected to transduction with
neurotrophin-encoding AdV vector. When compared with AdV-
LacZ-transduced OEG implanted rats, fewer errors were observed in
animals implanted with AdV-BDNF-transduced OEG, but this just
did not reach statistical significance ( p 
0.07). However, statistically significant im-
provements were obtained after implanta-
tion of AdV-NT-3 OEG ( p 0.02) or AdV-
BDNF/NT-3-transduced OEG ( p 0.009).
Together, these data demonstrate that
neurotrophin-encoding AdV vector-
transduced OEG implants showed the best
recovery after injury, whereas all OEG-
implanted animal groups were significantly
less impaired than unimplanted lesioned
controls.
Interestingly, a significant positive cor-
relation existed between the error scores of
the impaired (left) hindpaw of individual
animals and accompanying lesion vol-
umes (Pearson’s correlation test; r 
0.632; p 0.001). Rats that performed well
during horizontal rope walking (low error
score) were found to have relatively small
lesions, whereas animals that slipped or
fell from the rope more frequently consis-
tently had bigger lesion volumes (Fig. 9D).
This suggests that possible neuroprotec-
tive effects of BDNF and NT-3, counter-
acting secondary degeneration, positively
influenced the functional performance of
animals during horizontal rope locomo-
tion, which would also be in line with the
time course of recovery.
Discussion
The present study uniquely combined
OEG implantation with ex vivo AdV
vector-mediated neurotrophin gene trans-
fer. We demonstrate the following: (1) OEG
implants transduced with neurotrophin-
encoding AdV vectors augmented enhanced
recovery of hindlimb function compared
with controls as determined by behavioral
testing. (2) Lesion volumes were smaller in
OEG-implanted animals and significantly
reduced in size in rats receiving a graft that
was ex vivo transduced with neurotrophin-encoding AdV vector.
(3) A positive correlation did exist between functional impair-
ment and lesion size, indicating that reduction of secondary dam-
age by OEG implants leads to an improved functional outcome.
(4) Extensive BDNF-stimulated sprouting of RST axons was in-
duced up to 1–1.5 mm into the lesion area, but there was no
obvious correlation with behavioral data. Quantitative histolog-
ical and electrophysiological analysis showed that OEG did not
induce major long-distance RST regeneration. Therefore, the
correlation between lesion size and functional performance indi-
cates that the recovery was at least partially related to protective
effects of OEG implants on the surrounding spinal cord.
Functional performance correlates with lesion size
All OEG-implanted animals displayed better functional perfor-
mance during horizontal rope walking, which was also enhanced
in rats receiving an implant of neurotrophin-encoding AdV
vector-transduced OEG. Functional studies on the physiological
role of the red nucleus have demonstrated that its specific abla-
tion results in persistent, although minor, deficits in hindlimb
Figure 5. Graphic representation of the regenerative response of BDA-traced RST axons after implantation of AdV vector-
transduced OEG 4 months after injury. Top, Schematic representation of spinal cord lesion model and OEG injection sites. RN, Red
nucleus. Camera lucida drawings made of representative animals from each experimental group are shown. Note the distribution
pattern of BDA-traced RST axons (black) and their collaterals in the spinal cord gray matter (light gray area) at the injury site (gray
area). The latter contained both scar-associated cells and implanted OEG. NTs, BDNF plus NT-3. Scale bar, 450m.
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functioning (Muir and Whishaw, 2000).
This suggests that the observed impair-
ments in hindlimb performance during
horizontal rope walking were not only at-
tributable to a loss of rubral input. Dam-
age to other motor pathways in the lateral
funiculus (Holstege, 1991) likely contrib-
uted to these remaining deficits. The strik-
ing correlation between lesion size and
functional performance indicates that the
degree of recovery was likely related to the
protective potential of OEG implants,
which is a novel finding. Recently, OEG-
mediated tissue sparing has been described
in a contusion injury model (Takami et al.,
2002; Plant et al., 2003). However, it re-
mained to be elucidated whether this also
improved functional recovery. A signifi-
cant reduction in lesion size was found
only after implantation of OEG trans-
duced with neurotrophin-encoding AdV
vectors. This indicates that BDNF and
NT-3 counteracted secondary tissue de-
generation. Such a restorative role for neu-
rotrophins was proposed previously.
BDNF has been shown to reduce tissue ne-
crosis after spinal cord injury (Novikova et
al., 1996). This feature is important be-
cause spinal tissue sparing, in particular
ventrolateral white matter, has been di-
rectly related to the locomotor capacity of
spinal cord-injured rats (Schucht et al.,
2002). Furthermore, both BDNF and
NT-3 have been found to induce oligoden-
drocyte proliferation and remyelination of
damaged axons (McTigue et al., 1998),
which is of interest because remaining def-
icits after injury are partly caused by demyelination of spared
axons.
Together, we demonstrate that lesion size directly appeared to
influence impaired hindlimb performance. This supports the
idea that neurotrophin-mediated tissue preservation after im-
plantation of AdV vector-transduced OEG in the subacute phase
after injury contributed to the level of functional recovery rather
than regeneration of the RST itself.
AdV vector-transduced OEG implants and RST regeneration
Genetic modification allowed us to manipulate the growth-
promoting properties of OEG. In vitro, transduction of OEG with
AdV-BDNF or AdV-NT-3 resulted in a cell type that was more
effective in promoting neurite growth. In vivo, only AdV-BDNF-
transduced OEG were capable of inducing a significant regener-
ative response of RST axons. In previous work, using ex vivo
lentiviral vector-transduced OEG expressing the marker protein
green fluorescent protein to reliably track implanted cells, we
unequivocally demonstrated that implanted OEG did survive in
the lesioned spinal cord at least up to 4 months (Ruitenberg et al.,
2002). This indicates that under these conditions and in the ab-
sence of elevated BDNF levels, lesioned RST axons do not ro-
bustly respond to OEG implants. To date, a number of axon
populations were reported to regenerate through OEG implants
in different injury models, including sensory axons of the dorsal
root axons (Ramon-Cueto and Nieto-Sampedro, 1994; Navarro
et al., 1999) as well as serotonergic axons (Ramon-Cueto et al.,
1998, 2000; Lu et al., 2001a, 2002) and CST axons (Li et al., 1998;
Ramon-Cueto et al., 2000). Some controversy has arisen on the
regenerative response of the CST because others found that OEG-
induced sprouting was limited to the proximal injury site as ob-
served here for the RST (Takami et al., 2002; D. B. Levison, M. J.
Ruitenberg, G. W. Plant, unpublished observations). It is there-
fore important to obtain more insight in both OEG cell biology
and specific neurotrophic requirements of the different spinal
pathways. Extended knowledge of proteins involved in regener-
ation of specific nerve tracts will allow the development of more
optimal bridging substrates via genetic engineering.
Intraparenchymal infusions of BDNF induce enhanced regen-
eration of supraspinal axons, including the RST (Xu et al., 1995;
Kobayashi et al., 1997). However, a gene therapy-based strategy
to deliver neurotrophins has several advantages over the use of
osmotic minipumps (for review, see Dijkhuizen and Verhaagen,
1999). To date, engineered Schwann cells (Menei et al., 1998) and
fibroblasts (Liu et al., 1999; Lu et al., 2001b) have been used to
deliver BDNF to the injured spinal cord. Vigorous growth of RST
axons was reported after implantation of BDNF-secreting fibro-
blasts (Liu et al., 1999). In the present study, only short-range
BDNF-mediated sprouting was observed. This discrepancy in ex-
perimental outcome between our study and the findings of Liu et
al. (1999) is likely explained by several differences in treatment
conditions (i.e., the duration of transgene expression and num-
Figure 6. Quantitative analysis of the regenerative response of lesioned RST axons after implantation of different types of AdV
vector-transduced OEG. To compensate for variability in RST-tracing efficiency, fiber counts at 3 mm proximal to the lesion were
set as 100%, and all other points calculated were set as relative percentages. Data are presented as averages	 SEM. The shaded
area visualizes the outer confines of the distribution pattern of BDA-traced RST axon counts in the control groups (“lesion only” and
uninfected or AdV-LacZ-transduced OEG, respectively). Top, Left, No statistically significant differences in the number of RST fibers
were found after implantation of uninfected OEG ( p 0.52) or AdV-LacZ-transduced OEG ( p 0.12), respectively. Top, Right,
Implantation of AdV-NT-3-transduced OEG did not induce a regenerative response of lesioned RST axons compared with animals
that received either no implant or a graft of uninfected or AdV-LacZ-transduced OEG, respectively (controls; p 0.28). Bottom,
Left, Right, Quantification of the regenerative response of RST axons after implantation of AdV-BDNF-transduced OEG or OEG
transduced with both BDNF and NT-3-encoding AdV vectors. RST axon counts revealed that these grafts prevented axonal dieback
and induced sprouting of axotomized RST axons into the lesion area ( p0.0001). No significant differences were found between
these two groups ( p 0.33), indicating that coexpression of BDNF and NT-3 had no synergistic or counteracting effect on RST
outgrowth.
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ber of implanted cells). Most importantly, AdV vector-mediated
transduction of OEG results in a transient time course of trans-
gene expression after implantation in the lesioned spinal cord (up
to 30 d) (Ruitenberg et al., 2002), whereas persistent expression
and thereby continuous neurotrophic support is provided by en-
gineered fibroblast grafts. In future studies, it is therefore impor-
tant to study RST regeneration after implantation of stable trans-
duced OEG [e.g., using lentiviral vector-mediated gene transfer,
which results in persistent transgene expression (Ruitenberg et
al., 2002), and compare those implants directly to grafts of engi-
neered fibroblasts]. Ideally, neurotrophin expression should be
regulated to allow modulation of neurite outgrowth (Blesch et al.,
2000, 2001) and prevent entrapment of axons in areas with high
neurotrophic factor expression (Kirik et al., 2000).
Sprouting of RST axons preferentially occurred along the in-
terface of the lesion area and intact spinal cord. This was also
observed by Liu et al. (1999) and suggests that, in the presence of
elevated neurotrophin levels, reactive glia may act as an attractive
area for lesioned axons to grow (Kawaja and Gage, 1991). Alter-
natively, RST axons may try to avoid the lesion core that, besides
implanted OEG, also contains scar-associated cells (e.g., menin-
geal cells). Several growth inhibitory molecules have been associ-
ated with these cells and may repel growing RST axons from this
area (for review, see Fawcett and Asher, 1999; Pasterkamp et al.,
1999; De Winter et al., 2002).
Implantation of NT-3-producing OEG did not elicit a growth
response of axotomized RST axons. Although the receptors for
BDNF and NT-3, TrkB and TrkC, are coexpressed on rubrospinal
neurons, these neurotrophins seem to have distinct roles after
injury. NT-3 reportedly counteracts injury-induced death in
newborn rats (Diener and Bregman, 1994) but, in contrast to
BDNF, does not elicit regeneration-associated gene expression or
reverse lesion-induced atrophy during adulthood (Kobayashi et
al., 1997). This suggests a role for NT-3 in survival of RST neu-
rons rather than axonal regeneration, which is opposite for the
CST, in which BDNF was shown to promote survival but not
regeneration (Lu et al., 2001b).
Figure 7. OEG implants reduce lesion size after implantation in the lesioned rat spinal cord.
A, Example of lesion size determination in an OEG implanted animal using dark-field micros-
copy. Top, A discontinuity of normal spinal cord cytoarchitecture and a high density of small cells
that invaded the injury site clearly defined the borders of the damaged area. Bottom, Comput-
erized image analysis picture showing the outlined damaged (shaded) area to determine lesion
size. gm, Gray matter; wm, white matter. B, Graphic representation showing lesion volumes in
cubic millimeters (average 	 SEM). A consistent trend toward smaller lesion volumes was
found in all OEG-implanted animals. Significant reduction in lesion size was found only after
implantation of AdV-BDNF-, AdV-NT-3-, or AdV-BDNF plus AdV-NT-3-transduced OEG, respec-
tively. Asterisks indicate statistically significant differences ( p 0.05) from lesioned unim-
planted controls.
Figure 8. Four examples of representative rubrospinal MEP recordings from an intact and
lesioned control and after AdV vector-transduced OEG implantation. After unilateral transection
of the dorsolateral funiculus, a significant decrease ( p 0.001) in the amplitude of the first
peak was observed in all groups compared with age-matched unlesioned control animals (ar-
row). No treatment-based statistical differences in amplitude of this peak were observed
among experimental groups, which indicates the absence of robust and functional RST regen-
eration. Calibration: 10V, 1 msec.
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After implantation of a peripheral
nerve graft, regeneration of RST fibers has
been observed (Richardson et al., 1984).
Despite the fact that Schwann cells appear
more potent growth promoters for RST
axons, evidence is emerging that they do
not interact well with a CNS environment
and upregulate inhibitory chondroitin-
sulfate proteoglycan expression in astro-
cytes (Plant et al., 2001; Takami et al.,
2002). Therefore, OEG could be better
candidates as cellular platforms for ex vivo
gene transfer to repair the injured spinal
cord. Furthermore, in contrast to geneti-
cally modified fibroblasts, OEG are of CNS
origin and normally express a subset of
factors that support neurite outgrowth
(for review, see Ramon-Cueto and Avila,
1998; Woodhall et al., 2001).
The combination of neural transplan-
tation and neurotrophin delivery has
emerged as a promising strategy to aug-
ment regeneration and functional recov-
ery after spinal cord injury (for review, see
Bunge, 2001; Blits et al., 2002). We dem-
onstrate that ex vivo transduction of OEG
with BDNF- or NT-3-encoding AdV vec-
tors did: (1) significantly reduce lesion
size, (2) enhance the growth-promoting
properties of these cells, and (3) improve
functional recovery after implantation. A
limitation of AdV vector-transduced OEG
implants is that they did not induce robust
growth of RST axons distal from the injury
site, which is essential to restore damaged
neural networks. Stable transduction of
OEG with neurotrophin-encoding lentivi-
ral vectors could significantly improve the
results obtained, giving hope for the use of
these modified cells in both acute and
chronic spinal cord injury models.
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